Identifying an early indicator of drug efficacy in patients with metastatic colorectal cancer-a prospective evaluation of circulating tumor cells, 18F-fluorodeoxyglucose positron-emission tomography and the RECIST criteria.
Ann Oncol
; 28(7): 1576-1581, 2017 Jul 01.
Article
in En
| MEDLINE
| ID: mdl-28379285
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Colorectal Neoplasms
/
Radiopharmaceuticals
/
Fluorodeoxyglucose F18
/
Multidetector Computed Tomography
/
Response Evaluation Criteria in Solid Tumors
/
Positron Emission Tomography Computed Tomography
/
Neoplastic Cells, Circulating
/
Antineoplastic Agents
Type of study:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Ann Oncol
Journal subject:
NEOPLASIAS
Year:
2017
Document type:
Article
Country of publication: